BARCA, EMANUELE
 Distribuzione geografica
Continente #
NA - Nord America 1.018
EU - Europa 835
AS - Asia 257
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.111
Nazione #
US - Stati Uniti d'America 1.016
IE - Irlanda 319
SE - Svezia 271
CN - Cina 228
IT - Italia 63
PL - Polonia 52
FI - Finlandia 47
DE - Germania 24
GB - Regno Unito 21
IN - India 18
BE - Belgio 16
NL - Olanda 7
UA - Ucraina 6
IR - Iran 5
FR - Francia 4
VN - Vietnam 4
CA - Canada 2
RU - Federazione Russa 2
AT - Austria 1
CH - Svizzera 1
EU - Europa 1
KR - Corea 1
NO - Norvegia 1
SG - Singapore 1
Totale 2.111
Città #
Dublin 318
Chandler 210
Nyköping 150
Beijing 73
Dearborn 66
Ann Arbor 61
Jacksonville 59
Princeton 54
Warsaw 52
Cambridge 51
Medford 50
Ashburn 47
Des Moines 40
New York 25
Jinan 23
San Mateo 23
Messina 22
Wilmington 21
Shenyang 19
Boardman 16
Lancaster 16
Brussels 14
Ningbo 14
Nanjing 12
Hangzhou 11
Los Angeles 11
Hebei 10
Houston 10
Hyderabad 10
Bremen 9
Taizhou 8
Changsha 7
Haikou 7
Tianjin 7
Cagliari 6
Rome 6
Zhengzhou 6
Norwalk 5
Catania 4
Dong Ket 4
Fairfield 4
Pune 4
Washington 4
Ardabil 3
Falls Church 3
Fuzhou 3
Guangzhou 3
Helsinki 3
Mineo 3
Nanchang 3
Strasbourg 3
Torino 3
Hefei 2
Jiaxing 2
Las Vegas 2
Leawood 2
Milan 2
Monmouth Junction 2
Montreal 2
Seattle 2
Taiyuan 2
Waanrode 2
Augusta 1
Avigliano 1
Chaoyang 1
Gorey 1
Grafton 1
Kunming 1
Lanzhou 1
Milazzo 1
Mumbai 1
Naples 1
Nürnberg 1
Oslo 1
Sabz 1
Tappahannock 1
Tomsk 1
Vienna 1
Whiteville 1
Woodbridge 1
Totale 1.634
Nome #
Intracranial arterial abnormalities in patients with late onset Pompe disease (LOPD) 83
The Role of Mitochondria in Cerebellar Ataxias 73
Impaired Muscle Mitochondrial Biogenesis and Myogenesis in Spinal Muscular Atrophy 72
Risk of Myopathy in Patients in Therapy with Statins: Identification of Biological Markers in a Pilot Study 71
Clinical and molecular aspects of 30 patients with late-onset Pompe disease (LOPD): unusual features and response to treatment 65
Anti-Oxidant Drugs: Novelties and Clinical Implications in Cerebellar Ataxias 63
Auditory system involvement study in 20 patients with late-onset Pompe disease 58
Ruolo patogenetico dei microRNAs nelle calpainopatie 55
A study of auditory system in 20 patients with late onset Pompe disease 54
Are there ERT defined guidelines for Pompe disease? 54
ANT1 is reduced in sporadic inclusion body myositis. 53
A life threatening case of β-enolase deficiency 51
Clinical and electrophysiological characterization in a cohort of italian patients with different forms of hereditary spastic paraplegia 51
The Italian Mitochondrial Registry: design and preliminary results 51
Lipomatosis Incidence and Characteristics in an Italian Cohort of Mitochondrial Patients 51
Muscle imaging findings in GNE myopathy. 50
AUDITORY SYSTEM INVOLVEMENT IN LATE ONSET POMPE DISEASE: A STUDY OF 20 ITALIAN PATIENTS 50
ANO10 mutations cause ataxia and coenzyme Q₁₀ deficiency 48
Wound botulism in drug users: a still underestimated diagnosis 47
Metabolic Myoglobinuria 46
Auditory system involvement study in 20 patients with lateonset pompe disease 45
A MRI evaluation of respiratory function in patients with the late onset form of Pompe disease 45
Late-onset Pompe disease (LOPD): Correlations between respiratory muscles CT and MRI features and pulmonary function 45
Deoxynucleoside stress exacerbates the phenotype of a mouse model of mitochondrial neurogastrointestinal encephalopathy 45
Clinical features and new molecular findings in muscle phosphofructokinase deficiency (GSD type VII). 44
Differential expression of microRNAs in primary and secondary calpainopathies 44
Clinical, morphological and genetic features of a large cohort of late onset GSDII patients: typical and atypical presentation 43
An unusual clinical presentation of Pompe disease charactherized by a severe distal myopathy 43
CEREBELLAR ATAXIA AND SEVERE MUSCLE CoQ10 DEFICIENCY IN A PATIENT WITH A NOVEL MUTATION IN ADCK3 43
Chapter 34 - Primary Cerebellar CoQ10 Deficiency 41
The clinical heterogeneity of coenzyme Q10 deficiency results from genotypic differences in the Coq9 gene 40
Un caso di rabdomiolisi massiva da deficit di β-enolasi 39
Facial onset sensory motor neuronopathy: not always a slowly progressive disorder. 38
Differential expression of microRNAs in primary and secondary calpainopathies 37
CoQ10 Deficiency Is Not a Common Finding in GLUT1 Deficiency Syndrome 37
Coenzyme Q deficiency causes impairment of the sulfide oxidation pathway 33
Therapeutic approaches in the late onset form of GSD II 32
Deoxycytidine and Deoxythymidine Treatment for Thymidine Kinase 2 Deficiency 30
Coinvolgimento muscolare in un caso di sindrome di Sweet (dermatosi neutrofila febbrile) 28
Cytochrome c Oxidase Activity Is a Metabolic Checkpoint that Regulates Cell Fate Decisions During T Cell Activation and Differentiation 28
Update on diagnostics of metabolic myopathies 28
Role of the autophagic process in adult-onset patients with Pompe disease 27
Lack of aprataxin impairs mitochondrial functions via downregulation of the APE1/NRF1/NRF2 pathway 27
Functional cellular analyses reveal energy metabolism defect and mitochondrial DNA depletion in a case of mitochondrial aconitase deficiency 27
Inhibition of NAPDH Oxidase 2 (NOX2) Prevents Oxidative Stress and Mitochondrial Abnormalities Caused by Saturated Fat in Cardiomyocytes 27
Muscle gene expression profile in adult onset patients with Pompe disease 26
Role of the autophagic process in adult-onset patients with Pompe disease 26
Decreased Coenzyme Q10 Levels in Multiple System Atrophy Cerebellum 25
New motor outcome function measures in evaluation of Late-Onset Pompe disease before and after enzyme replacement therapy 22
Quantitative muscle MRI and functional measures in a cohort of late onset GSD II patients 21
Ruolo del processo autofagico nella forma ad insorgenza adulta di malattia di Pompe 20
Totale 2.202
Categoria #
all - tutte 8.440
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.440


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191 0 0 0 0 0 0 0 0 0 0 0 1
2019/2020204 2 0 1 1 4 64 19 9 8 47 37 12
2020/2021317 11 9 100 9 61 7 15 12 9 46 29 9
2021/2022395 3 40 4 25 19 4 35 18 8 67 56 116
2022/2023828 61 86 28 57 60 92 3 48 360 3 25 5
2023/2024180 22 26 21 19 17 37 1 14 1 20 2 0
Totale 2.202